Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06793683

Early BOTOX After Spinal Cord Injury

Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury

Status
Enrolling By Invitation
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators would like to improve our understanding of how early intervention with the use of bladder chemodenervation can preserve bladder function in those with a new SCI. Although detrimental cystometric and tissue changes are known to occur, often within 3 months after SCI, the investigators seek to document the time course of these changes and the range of severity of those changes in both those participants that receive prophylactic treatment and those who do not.

Conditions

Interventions

TypeNameDescription
DRUGBladder chemodenervation (Botox)BoNT-A (Botox) 200 U will be injected into the detrusor (bladder wall muscle).
PROCEDUREBladder Sham (Saline) Injection Procedure20mL placebo (saline only), will be injected into the detrusor (bladder wall muscle).

Timeline

Start date
2024-07-27
Primary completion
2028-04-30
Completion
2028-09-30
First posted
2025-01-27
Last updated
2025-01-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06793683. Inclusion in this directory is not an endorsement.